Cited by 142Epigenetics and DNA MethylationDementia and Cognitive Impairment ResearchGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

An epigenetic predictor of death captures multi-modal measures of brain health

Open access

Published version of a preprint

Abstract

Individuals of the same chronological age exhibit disparate rates of biological ageing. Consequently, a number of methodologies have been proposed to determine biological age and primarily exploit variation at the level of DNA methylation (DNAm). A novel epigenetic clock, termed ‘DNAm GrimAge’ has outperformed its predecessors in predicting the risk of mortality as well as many age-related morbidities. However, the association between DNAm GrimAge and cognitive or neuroimaging phenotypes remains unknown. We explore these associations in the Lothian Birth Cohort 1936 ( n = 709, mean age 73 years). Higher DNAm GrimAge was strongly associated with all-cause mortality over the eighth decade (Hazard Ratio per standard deviation increase in GrimAge: 1.81, P < 2.0 × 10 −16 ). Higher DNAm GrimAge was associated with lower age 11 IQ ( β = −0.11), lower age 73 general cognitive ability ( β = −0.18), decreased brain volume ( β = −0.25) and increased brain white matter hyperintensities ( β = 0.17). There was tentative evidence for a longitudinal association between DNAm GrimAge and cognitive decline from age 70 to 79. Sixty-nine of 137 health- and brain-related phenotypes tested were significantly associated with GrimAge. Adjusting all models for childhood intelligence attenuated to non-significance a small number of associations (12/69 associations; 6 of which were cognitive traits), but not the association with general cognitive ability (33.9% attenuation). Higher DNAm GrimAge associates with lower cognitive ability and brain vascular lesions in older age, independently of early-life cognitive ability. This epigenetic predictor of mortality associates with different measures of brain health and may aid in the prediction of age-related cognitive decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0616-9

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 DNAm GrimAge and its component surrogate markers predict mortality in the LBC1936. a Forest plot showing hazard ratios and 95% confidence intervals (horizontal lines) from Cox proportional hazard models for DNAm GrimAge and its constituent DNAm surrogate markers in the LBC1936 (n = 906, no. of deaths = 226 following nine years of follow-up). All associations with the exceptions of DNAm Leptin were significant. b Kaplan–Meier survival curve exhibiting the survival probabilities for the top (highest DNAm GrimAge) and bottom quartiles (lowest DNAm GrimAge) for DNAm GrimAge in the LBC1936 following 9 years of follow-up
Fig. 1 DNAm GrimAge and its component surrogate markers predict mortality in the LBC1936. a Forest plot showing hazard ratios and 95% confidence intervals (horizontal lines) from Cox proportional hazard models for DNAm GrimAge and its constituent DNAm surrogate markers in the LBC1936 (n = 906, no. of deaths = 226 following nine years of follow-up). All associations with the exceptions of DNAm Leptin were significant. b Kaplan–Meier survival curve exhibiting the survival probabilities for the top (highest DNAm GrimAge) and bottom quartiles (lowest DNAm GrimAge) for DNAm GrimAge in the LBC1936 following 9 years of follow-upCC BY · PubMed Central
Fig. 2 Cross-sectional association between age-adjusted DNAm GrimAge and cognitive, neuroimaging and physical traits in the LBC1936. Cognitive: An accelerated DNAm GrimAge was negatively associated with the general factor of cognitive ability, digit symbol coding, symbol search and matrix reasoning tasks. DNAm GrimAge was also associated with an increased mean four choice reaction time. Neuroimaging: Age-adjusted DNAm GrimAge was negatively associated with the ratios of white matter volume, brain volume and grey matter volume to intracranial volume, and positively associated with the ratio of volume of white matter hyperintensities to intracranial volume. Physical: An accelerated DNAm GrimAge was negatively associated with four measures of lung function: forced expiratory volume in 1 s, forced vital capacity, forced expiratory ratio and peak expiratory flow, as well as levels of iron, low-density lipoprotein cholesterol and total cholesterol. Age-adjusted DNAm GrimAge was positively associated with weight, levels of creatinine, body mass index as well as levels of C-reactive protein and interleukin-6. Horizontal lines indiciate 95% confidence intervals. BMI body mass index, CRP C-reactive protein, FCRT four choice reaction time, FER forced expiratory ratio, FEV forced expiratory volume, FVC forced vital capacity, GM grey matter, ICV intracranial volume, IL6 interleukin-6, LDL low-density lipoprotein, PEF peak expiratory flow, WM white matter, WHM white matter hyperintensities
Fig. 2 Cross-sectional association between age-adjusted DNAm GrimAge and cognitive, neuroimaging and physical traits in the LBC1936. Cognitive: An accelerated DNAm GrimAge was negatively associated with the general factor of cognitive ability, digit symbol coding, symbol search and matrix reasoning tasks. DNAm GrimAge was also associated with an increased mean four choice reaction time. Neuroimaging: Age-adjusted DNAm GrimAge was negatively associated with the ratios of white matter volume, brain volume and grey matter volume to intracranial volume, and positively associated with the ratio of volume of white matter hyperintensities to intracranial volume. Physical: An accelerated DNAm GrimAge was negatively associated with four measures of lung function: forced expiratory volume in 1 s, forced vital capacity, forced expiratory ratio and peak expiratory flow, as well as levels of iron, low-density lipoprotein cholesterol and total cholesterol. Age-adjusted DNAm GrimAge was positively associated with weight, levels of creatinine, body mass index as well as levels of C-reactive protein and interleukin-6. Horizontal lines indiciate 95% confidence intervals. BMI body mass index, CRP C-reactive protein, FCRT four choice reaction time, FER forced expiratory ratio, FEV forced expiratory volume, FVC forced vital capacity, GM grey matter, ICV intracranial volume, IL6 interleukin-6, LDL low-density lipoprotein, PEF peak expiratory flow, WM white matter, WHM white matter hyperintensitiesCC BY · PubMed Central
Fig. 3 Cross-sectional association between age-adjusted DNAm GrimAge and regional cortical volume in the LBC1936. Left panel: t values indicate the magnitude of the negative association (values have been flipped for visualisation purposes). An accelerated DNAm GrimAge was negatively associated with cortical volume. Right panel: Corresponding FDR-corrected P values indicate the spatial distribution of significant associations. FDR false discovery rate
Fig. 3 Cross-sectional association between age-adjusted DNAm GrimAge and regional cortical volume in the LBC1936. Left panel: t values indicate the magnitude of the negative association (values have been flipped for visualisation purposes). An accelerated DNAm GrimAge was negatively associated with cortical volume. Right panel: Corresponding FDR-corrected P values indicate the spatial distribution of significant associations. FDR false discovery rateCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 2

  1. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115. · DOI · Paper page
  2. Deary IJ, Gow AJ, Taylor MD, Corley J, Brett C, Wilson V, et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 2007;7:28. · DOI

Cited by

Sorted by citations

Metadata

Authors
Hillary, R. F., Stevenson, A. J., Cox, S. R., McCartney, D. L., Harris, S. E., Seeboth, A., Higham, J., Sproul, D., Taylor, A. M., Redmond, P., Corley, J., Pattie, A., Hernández, M. D. C. V., Muñoz-Maniega, S., Bastin, M. E., Wardlaw, J. M., Horvath, S., Ritchie, C. W., Spires-Jones, T. L., McIntosh, A. M., Evans, K. L., Deary, I. J., & Marioni, R. E.
Affiliations
  • University of Edinburgh (GB)
  • Edinburgh Cancer Research (GB)
  • UK Dementia Research Institute (GB)
  • University of California, Los Angeles (US)
  • Institute of Genetics and Cancer (GB)
Corresponding author
Marioni, Riccardo E.
Venue
Molecular Psychiatry
Published
2019-12-03
Volume
26
Issue
8
Pages
3806-3816
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2993770134
Cited by
139
References
70
Citations by year
2026: 16 · 2025: 26 · 2024: 14 · 2023: 26 · 2022: 22 · 2021: 21 · 2020: 14
FWCI
4.72
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • Alzheimer's Research UK (ARUK-PG2017B-10.)
  • Wellcome Trust (108890/Z/15/Z)
  • Fondation Leducq
  • U.S. Department of Health & Human Services | National Institutes of Health (R01AG054628)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
DNA methylation, epigenetic clocks, biological aging, mortality prediction, all-cause mortality, cognitive ability, child intelligence, brain volume, white matter hyperintensities, cognitive decline, Lothian Birth Cohort 1936, brain health
MeSH terms
Birth Cohort, Aged, Aging, Brain, Child, Humans, DNA Methylation, Epigenesis, Genetic, Epigenomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review